The global enteral nutrition market is predicted to reach $13,811.6 million by 2030, advancing at a CAGR of 6.2% during 2021–2030. This can be attributed to the growing aged population, rising number of premature births, and increasing incidence of malnutrition, which lead to an increase in ICU mortality.
Moreover, the surging prevalence of chronic conditions, such as cancer, diabetes, stroke, multiple sclerosis, dementia, chronic obstructive pulmonary disease, and chronic liver disease, will drive the need for enteral nutrition products that support patients with oral intake difficulties.
Furthermore, the rapid development in the number of home health agencies and nursing care facilities is increasing the need for these products, as these facilities support patients in their post-surgery rehabilitation. Such agencies serve a large number of older people who have facing difficulty in swallowing, which is expected to boost the adoption of nutrition products, thereby propelling the market growth.
The online pharmacies category is expected to witness the highest growth rate in the coming years. Due to the simplicity of purchase and customer-friendly services provided by online pharmacies, the number of online medical supply shops and mass distributors has expanded significantly in recent years. The internet has altered the traditional paradigm of medical nutrition supplement distribution by providing customers with new options and control over how they maintain their well-being and health. According to the National Health Services, four out of every five consumers in the U.S. search for medical items online before contacting a physician, and they also compare prices across retail stores and online pharmacies.
The cost of enteral nutrition products is comparatively lower than parenteral nutrition products. Therefore, these products are widely preferred. In addition, the enteral procedures are less invasive, in comparison to the parenteral. This type of nutrition has become more popular in old-age patients who are not capable of meeting their nutrient requirements with food or are unable to take food. These types of patients are provided enteral nutrition through tube feeding. Tube feeding is less costly and has fewer complications, as compared to parenteral nutrition. This nutrition feeding mode is also gaining popularity for long-term feeding, due to its affordable cost. Hence, the lower cost of the products is driving the market growth in this category.
Based on region, the APAC market is set to witness the highest CAGR during the forecast period, owing to the increase in the patient population suffering from diseases such as cancer, neurological disorders, gastrointestinal disorders, diabetes, and other chronic conditions. Furthermore, the growing geriatric population in emerging economies, development of the R&D sector, rise in healthcare reforms, and technological advancements are expected to boost product demand across the region in the coming years.
Moreover, the surge in the focus of leading manufacturers on expanding their geographical presence in emerging countries to capture high market share is expected to drive the growth of the market in the region. Additionally, the increasing disposable income and the rising per capita GDP spending in India and China are also fuelling the demand for enteral nutrition products.
Key players operating in the enteral nutrition market include Abbott Laboratories, B. Braun Melsungen AG, Danone S.A., Nestlé S.A., Fresenius Kabi AG, Reckitt Benckinser Group PLC, Global Health Products Inc., Hormel Foods Corporation, Meiji Holdings Co. Ltd., and Victus Inc.